Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin-deficient phenotype: a real world analysis
Tsur A, Cahn A, Hanoch L, Pollack R
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: a real-world retrospective study
Costa S, Miranda C, Elefante A, et al.
Diabetes Obes Metab. Pub. online 6 Mar 2025.
Leggi
Automated insulin delivery in elderly with type 1 diabetes: a prespecified analysis of the extension phase
Kudva YC, Henderson RJ, Kanapka LG, et al.
Diabetes Technol Ther. Pub. online 11 Mar 2025.
Leggi
An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
Blüher M
Diabetes Obes Metab. Pub. online 11 Mar 2025.
Leggi
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: a post hoc analysis of the SURPASS clinical trial programme
Bergman BK, Rosenstock J, Garvey WT, et al.
Diabetes Obes Metab. Pub. online 13 Mar 2025.
Leggi
Association of diet and waist-to-hip ratio with brain connectivity and memory in aging
Jensen DEA, Ebmeier KP, Akbaraly T, et al.
JAMA Netw Open. 2025;8(3):e250171.
Leggi
Association of BMI with mortality and health-related quality of life among 4.4 million adults: evidence from a nationwide, population-based, prospective cohort study
Wu Y, Lin C, Wang C, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: results from the Veradigm® database
Hunter Gibble T, Chinthammit C, Ward JM, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Continuous ranibizumab via port delivery system vs monthly ranibizumab for treatment of diabetic macular edema: the pagoda randomized clinical trial
Khanani AM, Campochiaro PA, Graff JM, et al.
JAMA Ophthalmol. 2025:e250006.
Leggi
Port delivery system with ranibizumab vs monitoring in nonproliferative diabetic retinopathy without macular edema: the pavilion randomized clinical trial
Pieramici DJ, Awh CC, Chang M, et al.
JAMA Ophthalmol. 2025:e250001.
Leggi